Overview


According to FutureWise analysis the syringes and cannulas market in 2025 is US$ 20.03 billion, and is expected to reach US$ 27.22 billion by 2033 at a CAGR of 3.9%. The market is experiencing growth due to rising demand for vaccination programs and an increase in chronic diseases that require regular medication. Advancements in minimally invasive surgical techniques, along with a shift toward safety-engineered devices and the expansion of healthcare infrastructure in emerging economies, are further driving market adoption.

Syringes and cannulas are essential medical devices that play a crucial role in healthcare delivery. They are used for administering medications, drawing fluids, and performing diagnostic or therapeutic procedures. Syringes are piston-driven instruments that deliver precise volumes of liquid, typically through a needle or cannula, while cannulas are hollow tubes inserted into the body to facilitate fluid delivery or removal. Together, these tools are vital in various medical settings, from routine vaccinations to complex surgical interventions.

Syringes consist of a barrel, plunger, and tip, often fitted with a needle or designed to connect to a cannula. They come in various sizes, ranging from small insulin syringes (0.3-1 mL) to larger ones (up to 60 mL) for diverse applications such as injections, irrigation, or enteral feeding. Made from materials like plastic or glass, they ensure durability and sterility, with disposable syringes being predominantly used today to prevent cross-contamination. Specialized syringes, such as auto-disable models, enhance safety in immunization programs.

Cannulas, typically made of metal or plastic, are commonly used in procedures like intravenous (IV) therapy, catheterization, or aspiration. IV cannulas, which include a needle for insertion and a flexible tube for prolonged access, are critical for administering fluids and medications or drawing blood. Their sizes, measured in gauge, determine the flow rates, with smaller gauges allowing for faster delivery. Cannulas are also utilized in specialties such as ophthalmology and cosmetic surgery for precise interventions.

These devices have transformed healthcare by enabling accurate dosing, reducing the risk of infections through sterile designs, and improving patient comfort with finer needles. However, challenges such as needle-stick injuries and improper disposal necessitate ongoing innovations, including safety-engineered syringes. As medical technology advances, syringes and cannulas continue to evolve, now incorporating features like smart sensors for dosage monitoring, ensuring safer and more effective patient care across various clinical scenarios.

Safety-Engineered Devices: Manufacturers are increasingly using safety-engineered syringes and cannulas to reduce the risk of needlestick injuries. These devices often include retractable needles or protective shields that activate immediately after use, improving safety for both patients and healthcare providers.

Smart Syringes with RFID and Sensors: The combination of Radio Frequency Identification (RFID) technology and sensors in syringes facilitates real-time tracking of dosages and usage. This advancement aims to minimize medication errors and enhance inventory management in healthcare settings.

  • Lifesciences Corporation,
  • Medtronic Plc.,
  • Becton,
  • Edwards Lifesciences Corporation,
  • B.Braun Melsungen AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Syringes and Cannulas Market:

Becton, Dickinson and Company

BD has increased syringe and IV catheter production capacity by 40-50% in the United States. This initiative aims to stabilize domestic supply chains and reduce reliance on imports, while also addressing concerns about the quality of syringes manufactured in China.

B.Braun Melsungen

B. Braun has launched a new line of biocompatible syringe cannulas to enhance patient safety and reduce the risk of infections during medical procedures.

By Product Type

  • Syringes
  • Cannulas

By End Users

  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Nursing Facilities
  • Others

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Here’s a regional view of where the most progress is happening:

The Asia-Pacific (APAC) region is witnessing significant growth in the syringes and cannulas market, driven by key factors such as growth rate, healthcare expansion, and the prevalence of chronic diseases.

North America has the largest market share for syringes and cannulas, with the United States at the forefront of demand and innovation.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Syringes And Cannulas Market By Product Type, By End Users, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Syringes and Cannulas Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Syringes and Cannulas Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Syringes and Cannulas Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Syringes and Cannulas Market, By Product Type Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Syringes
        2. Cannulas

  • 8.   Syringes and Cannulas Market, By End Users Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Hospitals
        2. Diagnostic Laboratories
        3. Clinics
        4. Nursing Facilities
        5. Others

  • 9.   North America Syringes and Cannulas Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 10.   Latin America Syringes and Cannulas Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 11.   Europe Syringes and Cannulas Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 12.   Asia Pacific Syringes and Cannulas Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 13.   Middle East and Africa Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Lifesciences Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Medtronic Plc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Becton
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Edwards Lifesciences Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. B.Braun Melsungen AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

FAQ


It includes medical devices used for injecting, withdrawing, or delivering fluids in healthcare settings. Syringes and cannulas are essential for therapies, vaccinations, blood sampling, IV administration, and minimally invasive procedures.

Disposable Syringes – Standard and prefilled syringes designed for single use.

Safety Syringes– Feature retractable needles or protective shields to prevent needlestick injuries.

IV Cannulas – Used for the delivery of intravenous fluids.

Catheter Cannulas– Provide vascular access for specialized therapies.

Ultra-thin Wall Cannulas – Designed for high flow rates while minimizing patient discomfort.

- Safety-engineered syringes and cannulas are designed to minimize the risk of needlestick injuries.

- Smart syringes equipped with RFID and sensors allow for precise tracking of dosage and usage.

- Antimicrobial-coated cannulas help to reduce the risk of infection.

- Ultra-thin-walled cannulas provide improved flow and enhance patient comfort.

High costs of advanced syringes and cannulas hinder access. There is a limited number of trained healthcare professionals in emerging markets. Strict regulatory approvals can delay product launches. A consistent need for quality and infection control standards exists globally.

Related Market

Venipuncture Needles and Syringes Market

Read More

Disposable Syringes Market

Read More

Safety Syringes Market

Read More

Pediatric Nasal Cannula Market

Read More

Cannula Needles Market

Read More
Partner

Our Clients